The Economic and Human Imperative of Tobacco Control: Seizing the Opportunity to Save Lives and Costs

Abstract

Tobacco use claims 490,000 lives annually in the United States, imposing a $600 billion economic burden, including $240 billion in direct healthcare costs. Oral cancer, linked to smoking in 70% of cases, contributes significantly, with per-patient treatment costs often exceeding $100,000. Drawing on clinical and public health expertise from Pakistan, the United States, and Iran, this study analyzes the human and economic toll of tobacco use and evaluates the potential of tobacco control measures. A 10% reduction in U.S. smoking prevalence could prevent 48,000 deaths and save $60 billion annually, including $380 million from reduced oral cancer cases. Despite the cost-effectiveness of cessation programs, stakeholders—health insurers, Accountable Care Organizations (ACOs), medical groups, AARP, physician societies, the National Committee for Quality Assurance (NCQA), and academic institutions like Immaculata University—remain underengaged. The National Conference on Tobacco or Health (August 25–27, 2025, Chicago) offers a platform to mobilize these groups. We propose strategies to integrate tobacco control into healthcare and academic systems, emphasizing global and local solutions to save lives and reduce costs.